Approval · Notice of Compliance 5339 · 1994
NOVAMOXIN: Notice of Compliance 5339
Issued January 14, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5339
- Date
- January 14, 1994
- Company
- Novopharm LimitedMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NOVAMOXIN | Not yet assigned | — |
Medicinal ingredients
- AMOXICILLIN 250 MG per CAP
- AMOXICILLIN 500 MG per CAP
- AMOXICILLIN 125 MG per TAB
- AMOXICILLIN 250 MG per TAB
- AMOXICILLIN 25 MG per ML
- AMOXICILLIN 50 MG per ML